These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5084738)

  • 1. [Content of glutathione and its fractions in the blood in chronic glomerulonephritis].
    Bazanov IuI
    Vrach Delo; 1972 Feb; 2():44-6. PubMed ID: 5084738
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood serum content of sulfhydryl compounds in patients with chronic glomerulonephritis].
    Bazanov IuI
    Vrach Delo; 1974 Sep; 0(9):86-8. PubMed ID: 4428723
    [No Abstract]   [Full Text] [Related]  

  • 3. [State of blood coagulation in glomerulonephritis].
    Sakhno LP
    Vrach Delo; 1977 Nov; (11):107-9. PubMed ID: 595537
    [No Abstract]   [Full Text] [Related]  

  • 4. [Amino acid composition of blood proteins in chronic diffuse glomerulonephritis].
    Kudrin VM; Nikula TD
    Vrach Delo; 1971; (2):64-7. PubMed ID: 5099053
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphologic parameters of blood platelets and dysmorphic erythrocyturia in chronic glomerulonephritis].
    Mantur M; Jakubowska-Kuźmiuk I; Prokopowicz J; Kemona H; Dabrowska J
    Pol Merkur Lekarski; 1997 Sep; 3(15):119-21. PubMed ID: 9461707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Condition of the coagulating and fibrinolytic systems of the blood in patients with chronic diffuse glomerulonephritis].
    Belitskaia GA; Pyrig LA
    Vrach Delo; 1968 May; 5():67-70. PubMed ID: 5740460
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood phospholipids in patients with different clinical manifestations of chronic glomerulonephritis and preserved kidney function].
    Riabov SI; Kulikova AI; Mitrofanova OV
    Ter Arkh; 1995; 67(2):51-4. PubMed ID: 7725261
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphologic changes of erythrocytes in blood and dysmorphic erythrocyturia].
    Jakubowska-Kuźmiuk I; Mantur M; Prokopowicz J
    Przegl Lek; 1994; 51(10):425-7. PubMed ID: 7878195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid peroxides in the plasma of patients with chronic glomerulonephritis of the nephrotic type].
    Nikiforova NV; Sokolovskaia IV; Gonchar NA
    Ter Arkh; 1983; 55(6):39-41. PubMed ID: 6612619
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum and urine lysozyme in chronic pyelonephritis and chronic glomerulonephritis].
    Klein U; Klein YM; Stein G; Stelzner A
    Z Urol Nephrol; 1981 May; 74(5):375-84. PubMed ID: 7269823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-morphologic characteristics of chronic glomerulonephritis in patients with Botkin's disease].
    Shulutko BI
    Vrach Delo; 1969 Mar; 3():34-6. PubMed ID: 5369650
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipid peroxidation and the system of antioxidant protection in patients with chronic glomerulonephritis and normal kidney azoturic function].
    Riabov SI; Kulikova AI; Tugusheva FA; Zubina IM; Kozlov VV
    Ter Arkh; 1995; 67(12):33-7. PubMed ID: 8820054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin is increased and correlated with the degree of proteinuria, but plasma leptin is not changed in patients with chronic glomerulonephritis.
    Hayakawa K; Ohashi H; Yokoyama H; Yoshida G; Okada M; Minatoguchi S
    Nephrology (Carlton); 2009 Apr; 14(3):327-31. PubMed ID: 19207870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reliability and limits of determination of the serum complement concentration in post-streptococcal glomerulonephritis].
    Toso M; Gambari PF; Todesco S; Castellani A
    G Clin Med; 1967 Dec; 48(12):1317-47. PubMed ID: 5617383
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in total blood proteins, blood protein electrophoretic fractions and in blood glycoproteins in the course of acute glomerulonephritis in children].
    Moggi C; Berti S; Carattoli MT
    Riv Clin Pediatr; 1969; 82():302-5. PubMed ID: 5405483
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of health resort treatment on the south coast of the Crimea on lipid metabolism indices in chronic glomerulonephritis].
    Pyrig LA; Ratner ZG; Vinogradova VS; Shevchenko ZV; Mukhachev NN
    Vrach Delo; 1980 Dec; (12):84-7. PubMed ID: 7222590
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolomic identification of potential phospholipid biomarkers for chronic glomerulonephritis by using high performance liquid chromatography-mass spectrometry.
    Jia L; Wang C; Zhao S; Lu X; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(1):134-40. PubMed ID: 17996503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Haptoglobin types and chronic glomerulonephritis].
    Petzschmann S; Göbel U; Mohnike A; Geserick G; Natusch R; Dutz H
    Z Gesamte Inn Med; 1980 Jun; 35(11):452-4. PubMed ID: 7434836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effect of urokinase on chronic glomerulonephritis (group study).
    Abe T
    New Istanbul Contrib Clin Sci; 1978 Mar; 12(2):123-32. PubMed ID: 16302698
    [No Abstract]   [Full Text] [Related]  

  • 20. [Characteristics of the process of hemocoagulation in patients with chronic glomerulonephritis].
    Shul'tsev GP; Panchenko VM; Kuanyshbaev SK
    Klin Med (Mosk); 1969 Nov; 47(11):60-5. PubMed ID: 5380037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.